|
KR20150060579A
|
|
Method for Preparing 4-(3-(3-fluorophenyl)-5,5-dimethyl-4-oxo-4,5-dihydrofuran-2-yl)benzenesulfonamide
|
|
KR100989389B1
|
|
Novel crystalline ziprasidone hcl and processes for preparation thereof
|
|
KR20100135130A
|
|
A novel process for preparing montelukast or its sodium salt and a thiolactone and an amine salt intermediate for the process
|
|
KR100913689B1
|
|
Aqueous nanoemulsion composition containing conjugated linoleic acid
|
|
KR20100063915A
|
|
Method of preparing s-(-)-amlodipine with high optical purity and intermediate compound produced during the same
|
|
KR20030082525A
|
|
Intermediate for preparing levosulpiride and preparation method thereof
|
|
KR20030082526A
|
|
Intermediate for preparing levosulpiride and preparation method thereof
|
|
KR20040054203A
|
|
A process for the preparation of erdosteine
|
|
KR20040049044A
|
|
A process for the preparation of 1,2,3-tris(2-diethylaminoethoxy)benzene
|
|
KR20040027045A
|
|
Processes for the preparation of aromatic cyclic derivatives using palladium-loaded zeolite
|
|
KR20030073450A
|
|
Process for the preparation of 2-Hydroxy-N-(2-hydroxyethyl)-3-methoxy-5-(2-propenyl)benzamide
|
|
KR20030048748A
|
|
Process for the preparation of racemic alkyl 4-chloro-3-hydroxy butyrate
|
|
KR20020092123A
|
|
Method of preparing levosulpiride and intermediates used therein
|
|
KR20000060138A
|
|
Process for the preparation of 4-amino-5-hexenoic acid
|
|
KR20000009216A
|
|
The method for the preparation of aceclofenac
|
